We invite your comments and questions about Elestrin or any information you see on our Website. You can contact Azur Pharma about Elestrin at:
Customer Service: 866.833.3560
Medical Information: 800.890.3098
AZUR PHARMA, INC.
1818 Market St.
Suite 2350
Philadelphia, PA 19103
P: 215.832.3750
F: 215.832.3789
www.elestrin.com
www.azurpharma.com
Elestrin is a registered trademark of Azur Pharma Inc.
© 2009 Azur Pharma Inc.
All rights reserved
Important Safety InformationElestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia. Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of endometrial cancer. The most frequently reported adverse events in clinical trials were nasopharyngitis, breast tenderness, upper respiratory tract infection, and metrorrhagia.
Please see Full Prescribing Information, including Black Box Warning
© 2009 Azur Pharma Inc. 1818 Market Street, Suite 2350, Philadelphia, PA 19103
*Please note: When you access these resources, you are leaving the Elestrin Web site. Therefore, Elestrin and Azur Pharma Inc. do not endorse the accuracy of the information you may find. We encourage you to talk to your doctor about the accuracy of any information you discover through these Internet resources.
Agree and continueA Survey of 300 untreated menopausal women reveal what they want from the application of transdermal estrogen therapy†:
"I want a product I can apply and forget it."
"I’d rather just rub the product in and forget it’s there."
"For me, it’s easier to get into a daily habit."
"I like the control of applying [it] right on my upper arm."
"Make it clear and easy to apply."
†A blinded survey of 300 women with hot flashes to evaluate the importance of various attributes of transdermal estrogen therapy and the preference for various topical estrogen therapy products. Azur Pharma; 2009.